| Literature DB >> 35607807 |
Wenli Zhao1, Yue Liu2, Lijuan Xu1,2, Yuan He3, Zhenyu Cai1,3, Jianqiang Yu1, Wannian Zhang1,2, Chengguo Xing4, Chunlin Zhuang1,2, Zhuo Qu1.
Abstract
Alzheimer's disease (AD) is an irreversible and progressive neurodegenerative disorder featured by memory loss and cognitive default. However, there has been no effective therapeutic approach to prevent the development of AD and the available therapies are only to alleviate some symptoms with limited efficacy and severe side effects. Necroptosis is a new kind of cell death, being regarded as a genetically programmed and regulated pattern of necrosis. Increasing evidence reveals that necroptosis is tightly related to the occurrence and development of AD. This review aims to summarize the potential role of necroptosis in AD progression and the therapeutic capacity of targeting necroptosis for AD patients.Entities:
Keywords: Alzheimer’s disease; MLKL; RIPK1; RIPK3; necroptosis; therapy
Mesh:
Substances:
Year: 2022 PMID: 35607807 DOI: 10.1021/acschemneuro.2c00172
Source DB: PubMed Journal: ACS Chem Neurosci ISSN: 1948-7193 Impact factor: 5.780